Healthcare & Life Sciences Private Equity Deal Tracker: NovaQuest Invests in Bend Bioscience

Holly Buckley
McGuireWoods LLP
Contact
LinkedIn
Facebook
X
Send
Embed

NovaQuest Private Equity (NQPE) has invested in Bend Bioscience, according to a news release.

Bend Bioscience, based in Bend, Ore., is an early-phase contract development and manufacturing organization (CDMO). Founded in 2021, the company specializes in particle engineering, drug delivery, drug development and manufacturing to the pharmaceutical industry.

NQPE is a private equity firm that invests in lower middle market healthcare services and technology companies primarily in North America. It’s the private equity group of NovaQuest Capital Management, which is based in Raleigh, N.C., and was formed in 2000.

As a result of the investment, the Bend Bioscience team is now part of CDMO CoreRx.

Terms of the investment were not disclosed.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide